Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Gynecol Obstet ; 288(4): 805-14, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23553197

RESUMO

PURPOSE: To determine, with extended receiver operating characteristic (ROC) curve analysis, the diagnostic value of cytokines showing significantly different peritoneal concentrations between women with and without endometriosis. METHODS: Multiplex cytokine concentration measurement of IL-2, IL-4, IL-6, IL-10, TNF-α and IFN-γ levels in peritoneal fluid of women with minimal to mild (n = 10) and moderate to severe (n = 26) endometriosis, and 42 controls. RESULTS: Only IL-6 and IL-10 concentrations were significantly higher in endometriosis patients than in controls. Specifically, significantly higher IL-6 and IL-10 levels were found in moderate to severe but not in minimal to mild endometriosis as compared to controls. For evaluation of diagnostic significance, ROC analysis determined discriminating parameters for IL-6, while those calculated for IL-10 were useless. Importantly, ROC analysis for IL-6 levels limited to women with moderate to severe endometriosis showed the highest area under the curve with the sample size sufficient to achieve 90 % power of the test. Finally, extended ROC including cost of analysis for this group of patients determined the optimal cut-off leading to high specificity and positive likelihood ratio resulting in 79 % effectiveness of the test. CONCLUSIONS: While our outcomes show moderate usefulness of peritoneal IL-6 levels in discrimination of moderate to severe endometriosis, further studies might be needed to determine the usefulness of peritoneal IL-6 levels in detection of early stages of endometriosis, as such a finding would be more relevant in clinical decision making.


Assuntos
Líquido Ascítico/metabolismo , Endometriose/diagnóstico , Interleucina-6/metabolismo , Adulto , Biomarcadores/metabolismo , Estudos de Casos e Controles , Citocinas/metabolismo , Endometriose/metabolismo , Feminino , Humanos , Interleucina-10/metabolismo , Curva ROC , Índice de Gravidade de Doença , Regulação para Cima
2.
Pol Merkur Lekarski ; 18(105): 336-8, 2005 Mar.
Artigo em Polonês | MEDLINE | ID: mdl-15997647

RESUMO

Vulvar carcinoma accounts for 3-5% of all genital cancers. The most common histology of vulvar cancer is squamous cell carcinoma. It has been suggested that vulvar cancer exists as two separate diseases--HPV-positive, occurring in young women, and p53-positive, that occurs in older women. As extensive surgery resection is gold standard of treatment, it is important to play attention for all symptoms, suggesting the beginning of disease. Understanding of the anatomy and the mechanism of lymphatic spread have made modifications in surgical technique possible, allowing less radical excisions.


Assuntos
Carcinoma de Células Escamosas , Neoplasias Vulvares , Carcinoma de Células Escamosas/química , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/epidemiologia , Carcinoma de Células Escamosas/cirurgia , Carcinoma de Células Escamosas/virologia , Diagnóstico Diferencial , Feminino , História do Século XXI , Humanos , Papillomaviridae/isolamento & purificação , Proteína Supressora de Tumor p53/análise , Neoplasias Vulvares/química , Neoplasias Vulvares/diagnóstico , Neoplasias Vulvares/epidemiologia , Neoplasias Vulvares/cirurgia , Neoplasias Vulvares/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...